Details of the Drug

General Information of Drug (ID: DMHLIQU)

• Drug Name: ABBV-8E12
• Synonyms: C2N-8E12

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2	[1]
Progressive supranuclear palsy	8A00.10	Phase 2	[2]

• Cross-matching ID: TTD ID: D0H7KQ
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03712787) An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02985879) A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP). U.S. National Institutes of Health.